In preparation for expanded Veterinary Feed Directives (VFDs) on January 1, 2017, GlobalVetLINK (GVL®) has announced that current and transition FDA-approved VFD drugs are active in its FeedLINK® Electronic VFD System as of yesterday.
This means that veterinarians will be able to write VFDs for all of the drugs that will transition to VFD status, as long as they are written with an effective date of January 1, 2017. However, several drugs and combinations are still under evaluation by the FDA and/or drug manufacturers, so as those are finalized the system will be updated.
“We’ve continuously received questions about how to handle inventoried feed that will require a VFD on January 1, and whether or not VFDs can be written before that date,” explains Kaylen Henry, GVL Product Manager. “We’ve communicated to our customers that on December 13, the plan is that all of the drugs that have finalized their labels will be in the system, so they can work with their clients to get them what they need, when they need it.”
Beginning January 1, 2017, many of the antibiotics used for food animal production will require a VFD from a veterinarian.
“We have worked with all of the major animal health companies to update the drug label information in our system, and will continue to update these as any additional changes are made,” added Henry.
GlobalVetLINK has announced partnerships with animal health companies Elanco, Huvepharma, Merck Animal Health, Pharmgate and Phibro Animal Health Corporation and Zoetis.
The FeedLINK VFD system provides a tool for veterinarians, feed distributors and producers to manage VFDs in a 21 CFR Part 11 compliantonline software platform. GVL has provided FeedLINK to the industry since 2005.
Learn more about GlobalVetLINK